[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Blood Clotting Factor VIII Market Research Report 2021

August 2016 | 108 pages | ID: G1E39FA8E7FEN
QYResearch

US$ 2,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Blood Clotting Factor VIII

Revenue, means the sales value of Blood Clotting Factor VIII

This report studies Blood Clotting Factor VIII in Global market, especially in North America, Europe, China, Japan, India and Southeast Asia, focuses on top manufacturers in global market, with sales, price, revenue and market share for each manufacturer, covering
  • Amgen
  • AstraZeneca
  • Baxter
  • Britannia
  • Capricor
  • CSL Behring
  • GlaxoSmithKline
  • Grifols
  • Ferring
  • Janssen
  • NeuroDerm
  • Octapharma
  • Roche
  • Rhythm Metabolic
  • scPharmceuticals
  • SteadyMed
  • Takeda
  • United Therapeutics
  • UCB
  • US Worldmeds
Market Segment by Region, this report splits Global into several key Regions, with sales, revenue, market share and growth rate of Blood Clotting Factor VIII in these regions, from 2011 to 2021 (forecast), like
  • North America
  • China
  • Europe
  • Japan
  • India
  • Southeast Asia
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by application, this report focuses on sales, market share and growth rate of Blood Clotting Factor VIII in each application, can be divided into
  • Medical care
  • Hospital
  • Application 3
Global Blood Clotting Factor VIII Market Research Report 2021

1 BLOOD CLOTTING FACTOR VIII OVERVIEW

1.1 Product Overview and Scope of Blood Clotting Factor VIII
1.2 Blood Clotting Factor VIII Segment by Types
  1.2.1 Global Sales Market Share of Blood Clotting Factor VIII by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Blood Clotting Factor VIII Segment by Applications
  1.3.1 Medical care
  1.3.2 Hospital
  1.3.3 Application
1.4 Blood Clotting Factor VIII Market by Regions
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 India Status and Prospect (2011-2021)
  1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Blood Clotting Factor VIII (2011-2021)
  1.5.1 Global Blood Clotting Factor VIII Sales and Revenue (2011-2021)
  1.5.2 Global Blood Clotting Factor VIII Sales and Growth Rate (2011-2021)
  1.5.3 Global Blood Clotting Factor VIII Revenue and Growth Rate (2011-2021)

2 GLOBAL BLOOD CLOTTING FACTOR VIII MARKET COMPETITION BY MANUFACTURERS

2.1 Global Blood Clotting Factor VIII Sales and Share by Manufacturers (2015 and 2016)
2.2 Global Blood Clotting Factor VIII Revenue and Share by Manufacturers (2015 and 2016)
2.3 Manufacturers Blood Clotting Factor VIII Manufacturing Base Distribution and Product Type
2.4 Competitive Situation and Trends
  2.4.1 Expansions
  2.4.2 New Product Launches
  2.4.3 Acquisitions
  2.4.4 Other Developments

3 GLOBAL BLOOD CLOTTING FACTOR VIII ANALYSIS BY REGION

3.1 Global Blood Clotting Factor VIII Sales, Revenue and Market Share by Region (2011-2021)
  3.1.1 Global Blood Clotting Factor VIII Sales Market Share by Region (2011-2021)
  3.1.2 Global Blood Clotting Factor VIII Revenue Market Share by Region (2011-2021)
3.2 North America
  3.2.1 North America Blood Clotting Factor VIII Sales, Revenue and Price (2011-2021)
  3.2.2 North America Blood Clotting Factor VIII Sales, Revenue and Growth Rate (2011-2021)
3.3 Europe
  3.3.1 Europe Blood Clotting Factor VIII Sales, Revenue and Price (2011-2021)
  3.3.2 Europe Blood Clotting Factor VIII Sales, Revenue and Growth Rate (2011-2021)
3.4 China
  3.4.1 China Blood Clotting Factor VIII Sales, Revenue and Price (2011-2021)
  3.4.2 China Blood Clotting Factor VIII Sales, Revenue and Growth Rate (2011-2021)
3.5 Japan
  3.5.1 Japan Blood Clotting Factor VIII Sales, Revenue and Price (2011-2021)
  3.5.2 Japan Blood Clotting Factor VIII Sales, Revenue and Growth Rate (2011-2021)
3.6 India
  3.6.1 India Blood Clotting Factor VIII Sales, Revenue and Price (2011-2021)
  3.6.2 India Blood Clotting Factor VIII Sales, Revenue and Growth Rate (2011-2021)
3.7 Southeast Asia
  3.7.1 Southeast Asia Blood Clotting Factor VIII Sales, Revenue and Price (2011-2021)
  3.7.2 Southeast Asia Blood Clotting Factor VIII Sales, Revenue and Growth Rate (2011-2021)

4 GLOBAL BLOOD CLOTTING FACTOR VIII ANALYSIS BY TYPE

4.1 Global Blood Clotting Factor VIII Sales, Revenue, Market Share and Growth Rate by Type (2011-2021)
  4.1.1 Global Blood Clotting Factor VIII Sales and Market Share by Type (2011-2021)
  4.1.2 Global Blood Clotting Factor VIII Revenue, Market Share and Growth Rate by Type (2011-2021)
4.2 Type I Sales, Revenue, Price and Growth (2011-2020)
4.3 Type II Sales, Revenue, Price and Growth (2011-2020)
4.4 Type III Sales, Revenue, Price and Growth (2011-2020)

5 GLOBAL BLOOD CLOTTING FACTOR VIII MARKET ANALYSIS BY APPLICATION

5.1 Global Blood Clotting Factor VIII Sales and Market Share by Application (2011-2021)
5.2 Major Regions Blood Clotting Factor VIII Sales by Application in 2015 and 2016
  5.2.1 North America Blood Clotting Factor VIII Sales by Application
  5.2.2 Europe Blood Clotting Factor VIII Sales by Application
  5.2.3 China Blood Clotting Factor VIII Sales by Application
  5.2.4 Japan Blood Clotting Factor VIII Sales by Application
  5.2.5 India Blood Clotting Factor VIII Sales by Application
  5.2.6 Southeast Asia Blood Clotting Factor VIII Sales by Application

6 GLOBAL BLOOD CLOTTING FACTOR VIII MANUFACTURERS ANALYSIS

6.1 Amgen
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Blood Clotting Factor VIII Product Overview
    6.1.2.1 Type I
    6.1.2.2 Type II
    6.1.2.3 Type III
  6.1.3 Blood Clotting Factor VIII Sales, Revenue, Price of Amgen (2015 and 2016)
6.2 AstraZeneca
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Blood Clotting Factor VIII Product Overview
    6.2.2.1 Type I
    6.2.2.2 Type II
    6.2.2.3 Type III
  6.2.3 Blood Clotting Factor VIII Sales, Revenue, Price of AstraZeneca (2015 and 2016)
6.3 Baxter
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Blood Clotting Factor VIII Product Overview
    6.3.2.1 Type I
    6.3.2.2 Type II
    6.3.2.3 Type III
  6.3.3 Blood Clotting Factor VIII Sales, Revenue, Price of Baxter (2015 and 2016)
6.4 Britannia
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Blood Clotting Factor VIII Product Overview
    6.4.2.1 Type I
    6.4.2.2 Type II
  6.4.3 Blood Clotting Factor VIII Sales, Revenue, Price of Britannia (2015 and 2016)
6.5 Capricor
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Blood Clotting Factor VIII Product Overview
    6.5.2.1 Type I
    6.5.2.2 Type II
  6.5.3 Blood Clotting Factor VIII Sales, Revenue, Price of Capricor (2015 and 2016)
6.6 CSL Behring
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Blood Clotting Factor VIII Product Overview
    6.6.2.1 Type I
    6.6.2.2 Type II
  6.6.3 Blood Clotting Factor VIII Sales, Revenue, Price of CSL Behring (2015 and 2016)
6.7 GlaxoSmithKline
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Blood Clotting Factor VIII Product Overview
    6.7.2.1 Type I
    6.7.2.2 Type II
  6.7.3 Blood Clotting Factor VIII Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
6.8 Grifols
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Blood Clotting Factor VIII Product Overview
    6.8.2.1 Type I
    6.8.2.2 Type II
  6.8.3 Blood Clotting Factor VIII Sales, Revenue, Price of Grifols (2015 and 2016)
6.9 Ferring
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Blood Clotting Factor VIII Product Overview
    6.9.2.1 Type I
    6.9.2.2 Type II
  6.9.3 Blood Clotting Factor VIII Sales, Revenue, Price of Ferring (2015 and 2016)
6.10 Janssen
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Blood Clotting Factor VIII Product Overview
    6.10.2.1 Type I
    6.10.2.2 Type II
  6.10.3 Blood Clotting Factor VIII Sales, Revenue, Price of Janssen (2015 and 2016)
6.11 NeuroDerm
6.12 Octapharma
6.13 Roche
6.14 Rhythm Metabolic
6.15 scPharmceuticals
6.16 SteadyMed
6.17 Takeda
6.18 United Therapeutics
6.19 UCB
6.20 US Worldmeds

7 INDUSTRY POLICY ANALYSIS

8 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES AND FIGURES

Figure Picture of Blood Clotting Factor VIII
Figure Global Sales Market Share of Blood Clotting Factor VIII by Type in 2015
Table Blood Clotting Factor VIII Product Type of by Manufacturers
Table Blood Clotting Factor VIII Sales Market Share by Application in 2015 and 2016
Figure North America Blood Clotting Factor VIII Revenue and Growth Rate (2011-2021)
Figure China Blood Clotting Factor VIII Revenue and Growth Rate (2011-2021)
Figure Europe Blood Clotting Factor VIII Revenue and Growth Rate (2011-2021)
Figure Japan Blood Clotting Factor VIII Revenue and Growth Rate (2011-2021)
Figure India Blood Clotting Factor VIII Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Blood Clotting Factor VIII Revenue and Growth Rate (2011-2021)
Table Global Blood Clotting Factor VIII Sales and Revenue (2011-2021)
Figure Global Blood Clotting Factor VIII Sales and Growth Rate (2011-2021)
Figure Global Blood Clotting Factor VIII Revenue and Growth Rate (2011-2021)
Table Global Blood Clotting Factor VIII Sales of Key Manufacturers (2015 and 2016)
Table Global Blood Clotting Factor VIII Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Blood Clotting Factor VIII Sales Share by Manufacturers
Figure 2016 Blood Clotting Factor VIII Sales Share by Manufacturers
Table Global Blood Clotting Factor VIII Revenue by Manufacturers (2015 and 2016)
Table Global Blood Clotting Factor VIII Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Blood Clotting Factor VIII Revenue Share by Manufacturers
Table 2016 Global Blood Clotting Factor VIII Revenue Share by Manufacturers
Table Manufacturers Blood Clotting Factor VIII Manufacturing Base Distribution and Product Type
Table Global Blood Clotting Factor VIII Sales Market by Region (2011-2021)
Figure Global Blood Clotting Factor VIII Sales Market by Region (2011-2021)
Figure Global Blood Clotting Factor VIII Sales Market Share by Region (2011-2021)
Table Global Blood Clotting Factor VIII Revenue Market by Region (2011-2021)
Table Global Blood Clotting Factor VIII Revenue Market Share by Region (2011-2021)
Table North America Blood Clotting Factor VIII Sales, Revenue and Price (2011-2021)
Figure North America Blood Clotting Factor VIII Sales, Revenue and Growth Rate (2011-2021)
Table Europe Blood Clotting Factor VIII Sales, Revenue and Price (2011-2021)
Figure Europe Blood Clotting Factor VIII Sales, Revenue and Growth Rate (2011-2021)
Table China Blood Clotting Factor VIII Sales, Revenue and Price (2011-2021)
Figure China Blood Clotting Factor VIII Sales, Revenue and Growth Rate (2011-2021)
Table Japan Blood Clotting Factor VIII Sales, Revenue and Price (2011-2021)
Figure Japan Blood Clotting Factor VIII Sales, Revenue and Growth Rate (2011-2021)
Table India Blood Clotting Factor VIII Sales, Revenue and Price (2011-2021)
Figure India Blood Clotting Factor VIII Sales, Revenue and Growth Rate (2011-2021)
Table Southeast Asia Blood Clotting Factor VIII Sales, Revenue and Price (2011-2021)
Figure Southeast Asia Blood Clotting Factor VIII Sales, Revenue and Growth Rate (2011-2021)
Table Global Blood Clotting Factor VIII Sales by Type (2011-2021)
Table Global Blood Clotting Factor VIII Sales Share by Type (2011-2021)
Figure Sales Market Share of Blood Clotting Factor VIII by Type (2011-2021)
Figure Global Blood Clotting Factor VIII Sales Growth Rate by Type (2011-2021)
Table Global Blood Clotting Factor VIII Revenue by Type (2011-2021)
Table Global Blood Clotting Factor VIII Revenue Share by Type (2011-2021)
Figure Global Blood Clotting Factor VIII Revenue Growth Rate by Type (2011-2021)
Figure Type I Sales, Revenue and Growth (2011-2021)
Figure Type I Price Trend (2011-2021)
Figure Type II Sales, Revenue and Growth (2011-2021)
Figure Type II Price Trend (2011-2021)
Figure Type III Sales, Revenue and Growth (2011-2021)
Figure Type III Price Trend (2011-2021)
Table Global Blood Clotting Factor VIII Sales by Application (2011-2021)
Table Global Blood Clotting Factor VIII Sales Market Share by Application (2011-2021)
Figure Global Blood Clotting Factor VIII Sales Market Share by Application in 2015
Figure Global Blood Clotting Factor VIII Sales Market Share by Application in 2021
Table North America Blood Clotting Factor VIII Sales by Application (2015 and 2016)
Table Europe Blood Clotting Factor VIII Sales by Application (2015 and 2016)
Table China Blood Clotting Factor VIII Sales by Application (2015 and 2016)
Table Japan Blood Clotting Factor VIII Sales by Application (2015 and 2016)
Table India Blood Clotting Factor VIII Sales by Application (2015 and 2016)
Table Southeast Asia Blood Clotting Factor VIII Sales by Application (2015 and 2016)
Table Global Blood Clotting Factor VIII Sales Growth Rate by Application (2011-2021)
Figure Global Blood Clotting Factor VIII Sales Growth Rate by Application (2011-2021)
Table Amgen Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of Amgen (2015 and 2016)
Table AstraZeneca Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of AstraZeneca (2015 and 2016)
Table Baxter Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of Baxter (2015 and 2016)
Table Britannia Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of Britannia (2015 and 2016)
Table Capricor Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of Capricor (2015 and 2016)
Table CSL Behring Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of CSL Behring (2015 and 2016)
Table GlaxoSmithKline Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
Table Grifols Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of Grifols (2015 and 2016)
Table Ferring Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of Ferring (2015 and 2016)
Table Janssen Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of Janssen (2015 and 2016)
Table NeuroDerm Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of NeuroDerm (2015 and 2016)
Table Octapharma Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of Octapharma (2015 and 2016)
Table Roche Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of Roche (2015 and 2016)
Table Rhythm Metabolic Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of Rhythm Metabolic (2015 and 2016)
Table scPharmceuticals Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of scPharmceuticals (2015 and 2016)
Table SteadyMed Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of SteadyMed (2015 and 2016)
Table Takeda Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of Takeda (2015 and 2016)
Table United Therapeutics Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of United Therapeutics (2015 and 2016)
Table UCB Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of UCB (2015 and 2016)
Table US Worldmeds Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of US Worldmeds (2015 and 2016)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories